Sign In
Buy NARI
$79.97
+0 (+0%)
At Close: May 16, 2025
Shareholder Alert: Ademi LLP investigates whether Inari Medical, Inc. is obtaining a Fair Price for its Public Shareholders
05:02pm, Monday, 06'th Jan 2025
MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Inari (NASDAQ: NARI) for possible breaches of fiduciary duty and other violations of law in its transaction with the Stryker. Click here to learn
Inari Medical Catapults — Again — After Stryker Confirms $4.9 Billion Deal
04:48pm, Monday, 06'th Jan 2025
Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion late Monday. Inari stock catapulted on the news.
Exclusive: Medical device maker Stryker nearing a deal to buy Inari Medical, sources say
03:19pm, Monday, 06'th Jan 2025
Medical-device maker Stryker is in advanced talks to acquire Inari Medical , which makes devices that treat patients with venous diseases, people familiar with the matter told Reuters on Monday.
NEW YORK CITY, NY / ACCESSWIRE / January 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inari Medical, Inc. ("Inari" or "the Company") (NASDA
Reasons to Retain Inari Medical Stock in Your Portfolio for Now
09:35am, Friday, 03'rd Jan 2025
NARI continues to gain from its expanded product portfolio. The company's expansion in China and Japan bodes well.
Inari Medical to Present at the J.P. Morgan Healthcare Conference
08:00am, Friday, 03'rd Jan 2025
IRVINE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI), a medical device company with a mission to treat and transform the lives of patients suffering from venous and oth
NEW YORK CITY, NY / ACCESSWIRE / December 29, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inari Medical, Inc. ("Inari" or "the Company") (NAS
Bronstein, Gewirtz & Grossman, LLC Is Investigating Inari Medical, Inc. (NARI) And Encourages Stockholders to Connect
10:00am, Tuesday, 24'th Dec 2024
NEW YORK CITY, NY / ACCESSWIRE / December 24, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inari Medical, Inc. ("Inari" or "the Company") (NAS
NEW YORK CITY, NY / ACCESSWIRE / December 22, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inari Medical, Inc. ("Inari" or "the Company") (NAS
NEW YORK CITY, NY / ACCESSWIRE / December 18, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inari Medical, Inc. ("Inari" or "the Company") (NAS
Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Investors to Inquire about Securities Investigation
10:00am, Sunday, 15'th Dec 2024
NEW YORK CITY, NY / ACCESSWIRE / December 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inari Medical, Inc. ("Inari" or "the Company") (NAS
NEW YORK CITY, NY / ACCESSWIRE / December 12, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inari Medical, Inc. ("Inari" or "the Company") (NAS
Reasons to Retain Inari Medical Stock in Your Portfolio for Now
08:51am, Wednesday, 04'th Dec 2024
NARI continues to gain from its expanded product portfolio. The company's expansion in China and Japan bodes well.
NARI Stock Likely to Gain Following Reimbursement Approval in Japan
12:21pm, Tuesday, 03'rd Dec 2024
Inari Medical announces reimbursement approval for ClotTriever Thrombectomy System in Japan and a new distribution partnership with Medikit.
Reimbursement approval supports expanded access to effective, safe thrombus removal for patients suffering from deep vein thrombosis (DVT) in Japan Reimbursement approval supports expanded access to e
